GEODE CAPITAL MANAGEMENT, LLC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 32 filers reported holding REPROS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$86,000
+109.8%
131,1120.0%0.00%
Q3 2017$41,000
-31.7%
131,1120.0%0.00%
Q2 2017$60,000
-62.5%
131,112
-1.9%
0.00%
Q1 2017$160,000
-8.6%
133,676
+0.3%
0.00%
Q4 2016$175,000
-31.9%
133,328
+8.0%
0.00%
Q3 2016$257,000
+29.8%
123,434
+0.0%
0.00%
Q2 2016$198,000
+38.5%
123,376
-16.3%
0.00%
Q1 2016$143,000
-7.7%
147,473
+14.8%
0.00%
Q4 2015$155,000
-83.7%
128,483
+0.1%
0.00%
-100.0%
Q3 2015$953,000
+3.9%
128,367
+0.1%
0.00%0.0%
Q2 2015$917,000
-20.5%
128,256
-4.6%
0.00%0.0%
Q1 2015$1,154,000
-9.0%
134,375
+5.6%
0.00%0.0%
Q4 2014$1,268,000
+7.0%
127,269
+6.3%
0.00%0.0%
Q3 2014$1,185,000
-42.1%
119,760
+1.2%
0.00%0.0%
Q2 2014$2,047,000
-1.6%
118,347
+0.9%
0.00%0.0%
Q1 2014$2,080,000
+2.3%
117,255
+5.5%
0.00%0.0%
Q4 2013$2,034,000
-26.0%
111,175
+8.4%
0.00%
-50.0%
Q3 2013$2,749,000
+93.7%
102,565
+33.3%
0.00%
+100.0%
Q2 2013$1,419,00076,9250.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$11,210,0004.33%
DESTRIER CAPITAL MANAGEMENT LLC 933,600$9,243,0002.32%
SENZAR ASSET MANAGEMENT, LLC 753,600$7,460,0002.19%
ORACLE INVESTMENT MANAGEMENT INC 1,014,164$10,040,0001.39%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 775,307$7,675,0000.50%
Trellus Management Company, LLC 50,000$495,0000.42%
FNY Managed Accounts LLC 14,000$138,600,0000.42%
GENERAL AMERICAN INVESTORS CO INC 449,475$4,450,0000.36%
Baker Brothers Advisors 2,778,654$27,509,0000.35%
CQS Cayman LP 550,000$5,445,0000.32%
View complete list of REPROS THERAPEUTICS INC shareholders